In this webinar you can hear how a combination of generative chemistry and deep learning has impacted the design of new compounds in the search for novel antimalarials.

We were joined by our guest Professor Matthew Todd, Chair of Drug Discovery at University College London and founder of the Open Source Malaria initiative, which aims to find new medicines for the treatment of malaria, recognised by the World Health Organisation as one of the world’s deadliest diseases.

We described how Optibrium’s team deployed the in silico generative chemistry capabilities of StarDrop™ and the cutting-edge AI technologies of Augmented Chemistry™ in the Open Source Malaria (OSM) initiative, to design active compounds against a novel target in Plasmodium falciparum.

This webinar on AI-guided design of antimalarials was presented by Ben Irwin and Matthew Segall (Optibrium) and Professor Matthew Todd (University College London).

Meet the speakers

Matt Segall, PhD



The image shows Optibrium CEO Matthew Segall

Ben Irwin, PhD



Prof. Matthew Todd

University College London


More AI-guided discovery resources